Aft Pharms Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AFT PHARMS US, and when can generic versions of AFT PHARMS US drugs launch?
AFT PHARMS US has one approved drug.
There are three US patents protecting AFT PHARMS US drugs.
There are forty-seven patent family members on AFT PHARMS US drugs in thirty-three countries and one supplementary protection certificate in one country.
Summary for Aft Pharms Us
| International Patents: | 47 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Aft Pharms Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aft Pharms Us | COMBOGESIC | acetaminophen; ibuprofen | TABLET;ORAL | 209471-001 | Mar 1, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Aft Pharms Us | COMBOGESIC | acetaminophen; ibuprofen | TABLET;ORAL | 209471-001 | Mar 1, 2023 | RX | Yes | Yes | 11,534,407 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Aft Pharms Us | COMBOGESIC | acetaminophen; ibuprofen | TABLET;ORAL | 209471-001 | Mar 1, 2023 | RX | Yes | Yes | 10,532,036 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Aft Pharms Us Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United Kingdom | 0700027 | ⤷ Subscribe |
| Spain | 2381794 | ⤷ Subscribe |
| Australia | 2008202029 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Aft Pharms Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1781277 | PA2024501 | Lithuania | ⤷ Subscribe | PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
